Table 2 Demographic and Clinical Characteristics of the Study Cohort (N = 600)

Age, years

56.5 (14.1), 20–91

Time since COVID-19 diagnosis, days

35.7 (48.1), 1–271

n (%)

Sex

 Male

249 (41.5%)

 Female

351 (58.5%)

Marital status

 Married or living with partner

437 (72.8%)

 Single, divorced, or living alone

163 (27.2%)

Race

 White

517 (86.2%)

 Black

63 (10.7%)

 Asian

14 (2.3%)

 Native Hawaiian or Pacific Islander

1 (0.2%)

 American Indian or Alaskan Native

4 (0.7%)

Hispanic ethnicity

102 (17.0%)

Cancer diagnosis

 Solid tumor

483 (80.5%)

 Hematological cancers

117 (19.5%)

History of hospitalization for COVID infection

75 (12.5%)

EQ-5D-5 L scores at baseline

Utilities Index

0.82 (0.18), 0.02-1.00

VAS

78.3 (19.6), 0-100